In 2023, the market size value per capita for Penicillins and Streptomycins in Dosage in Italy stood at 11.74 USD. Forecasts from 2024 to 2028 show a gradual decline, with values decreasing from 11.71 to 11.60 USD. The year-on-year percentage variations indicate a consistent contraction. From 2024 to 2025, the market shrinks by approximately 0.34%, from 2025 to 2026 by 0.26%, and a similar trend continues through 2028. The Compound Annual Growth Rate (CAGR) across five years suggests a yearly average decline of around 0.24%.
Future trends to watch for include potential shifts due to healthcare policy changes, advancements in generic medications, and the increasing focus on antibiotic stewardship. Monitoring these factors will be critical for understanding the trajectory of market demand in Italy.
